Clinical Trial

Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Myomectomy was preferably applied in females with reproductive requirements, which could be achieved by transumbilical laparoendoscopic single-site surgery (TU-LESS) or multi-port laparoscopic surgery (MPLS). Power morcellation used in MPLS was correlated with unidentified risk of tumor dissemination, especially in cases with accidental surgical findings of uterine sarcoma or leiomyosarcoma. Moreover, TU-LESS was reported to exceed MPLS in fast recovery. Therefore, the aim of this prospective cohort study is to compare the effectiveness of fast recovery and relative risk of tumor dissemination between TU-LESS and MPLS in myomectomy for the treatment of uterine fibroids.
Trial Details
NCT Number NCT06244251
Lead Sponsor West China Second University Hospital
Conditions Uterine Fibroid, Uterine Sarcoma, Uterine Leiomyosarcoma
Enrollment 5,000 participants
Start Date 2023-06-24
Primary Completion 2026-08-24 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-02-06